Data / Form D filings / PierianDx, Inc.
PierianDx, Inc.: Form D filings
PierianDx, Inc., a biotechnology company in St. Louis, MO, filed 3 Form D notices with the SEC between 2018 and 2021. The latest, on November 9, 2021, reports $17 million sold of a $17 million offering to 13 investors.
Find out what PierianDx, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 6 Cityplace Drive, Suite 550, St. Louis, MO, 63141
- Phone
- (314) 628-0035
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1730902
The full lists. Form D filings in Missouri: 379 rows, $18.95, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 9, 2021 | New notice | $16,983,180 | $16,983,180 | $0 | 13 | Jun 23, 2021 | sec.gov |
| Nov 25, 2019 | New notice | $26,870,702 | $21,870,702 | $5,000,000 | 13 | Nov 12, 2019 | sec.gov |
| Feb 12, 2018 | New notice | $5,000,000 | $3,046,458 | $1,953,542 | 4 | Jan 29, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kerry Propper | Director | |
| Barnard Buscemi | Director | |
| Mark McDonough | Executive Officer, Director | |
| Rakesh Nagarajan | Executive Officer, Director | |
| Joseph Boorady | Director | |
| Frederick Hessler | Director | |
| Bryan Carey | Director |
Every Form D from the week of Nov 8, 2021 · All recent filings in Missouri · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what PierianDx, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.